TH148782B - Dosage form (S) - ethyl-2-amino-3- (4- (2- amino-6 - ((R) -1- (4- chloro-2- (3-methyl- 1H-pyrazol-1-il) phenyl) -2,2,2-trifluoroethoxy) pyrimidin-4-il) phenyl) propano Et ((S) -ethyl-2-amino-3- (4- (2-amino-6 - ((R) -1- (4-chloro-2- (3-methyl-1H-pyrazol-1-y1)) phenyl) -2,2,2-trifluoroethoxy) pyrimidin-4-yl) phenyl) propanoate) - Google Patents

Dosage form (S) - ethyl-2-amino-3- (4- (2- amino-6 - ((R) -1- (4- chloro-2- (3-methyl- 1H-pyrazol-1-il) phenyl) -2,2,2-trifluoroethoxy) pyrimidin-4-il) phenyl) propano Et ((S) -ethyl-2-amino-3- (4- (2-amino-6 - ((R) -1- (4-chloro-2- (3-methyl-1H-pyrazol-1-y1)) phenyl) -2,2,2-trifluoroethoxy) pyrimidin-4-yl) phenyl) propanoate)

Info

Publication number
TH148782B
TH148782B TH1401002078A TH1401002078A TH148782B TH 148782 B TH148782 B TH 148782B TH 1401002078 A TH1401002078 A TH 1401002078A TH 1401002078 A TH1401002078 A TH 1401002078A TH 148782 B TH148782 B TH 148782B
Authority
TH
Thailand
Prior art keywords
phenyl
amino
trifluoroethoxy
pyrazol
pyrimidin
Prior art date
Application number
TH1401002078A
Other languages
Thai (th)
Other versions
TH1401002078A (en
Inventor
แมทธิว เอส. ดีเวอร์ ริชาร์ด เจ. ฮอลล์ คัลยาน นูกูรู จินหลิง เฉิน
Original Assignee
เล็กซิคอน ฟาร์มาซูติคัลส์ อิงค์
Filing date
Publication date
Publication of TH1401002078A publication Critical patent/TH1401002078A/en
Application filed by เล็กซิคอน ฟาร์มาซูติคัลส์ อิงค์ filed Critical เล็กซิคอน ฟาร์มาซูติคัลส์ อิงค์
Publication of TH148782B publication Critical patent/TH148782B/en

Links

TH1401002078A 2012-10-16 Dosage form (S) - ethyl-2-amino-3- (4- (2- amino-6 - ((R) -1- (4- chloro-2- (3-methyl- 1H-pyrazol-1-il) phenyl) -2,2,2-trifluoroethoxy) pyrimidin-4-il) phenyl) propano Et ((S) -ethyl-2-amino-3- (4- (2-amino-6 - ((R) -1- (4-chloro-2- (3-methyl-1H-pyrazol-1-y1)) phenyl) -2,2,2-trifluoroethoxy) pyrimidin-4-yl) phenyl) propanoate) TH148782B (en)

Publications (2)

Publication Number Publication Date
TH1401002078A TH1401002078A (en)
TH148782B true TH148782B (en) 2016-04-18

Family

ID=

Similar Documents

Publication Publication Date Title
IL236495A0 (en) Heteroaromatic compounds as bruton's tyrosine kinase (btk)inhibitors
CL2014001765A1 (en) Process for the manufacture of 1- [2- (2,4-dimethylphenylsulfanyl) phenyl] piperazine.
DK3686193T3 (en) 2- (2,4,5-SUBSTITUTED ANILINO) PYRIMIDINE COMPOUNDS
DK2806859T3 (en) FORMULATIONS OF 3- (6- (1- (2,2-DIFLUOROBENZO [D] [1,3] DIOXOL-5-YL) CYCLOPROPANCARBOXAMIDO) -3-METHYLPYRIDIN-2-YL) BENZOIC ACID
SMT201500091B (en) Bis (fluoroachyl) -1,4-benzodiazepinone compounds
IL238571A0 (en) Bruton's tyrosine kinase inhibitors
DK3074396T3 (en) 1- (5-tert-butyl-2-arylpyrazole-3-yl) -3- [2-fluoro-4 - [(3-oxo-4H-pyrido [2,3-b] pyrazine-8-yl) oxy ] PHENYL] URINE DERIVATIVES AS RAF INHIBITORS FOR CANCER TREATMENT
UY34765A (en) NEW COMPOUNDS.
BR112013025792A2 (en) PYRROID-RELATED KINASE INHIBITORS [2,3-D] PYRIMIDINE TROPOMISINE
UY34778A (en) ? HEXAHYDROPIRANE COMPOUNDS [3,4-d] [1,3] HETEROCYCLIC TIAZIN-2-AMINA SUBSTITUTED.
BR112014031635A2 (en) (e) -n-methyl-n- ((3-methylbenzofuran-2-yl) methyl) -3- (7-oxo-5,6,7,8-tetrahydro-1,8-) prodrug derivatives naphthyrindin-3-yl) acrylamide
BR112015005361A2 (en) bruton tyrosine kinase inhibitors
DK3054927T3 (en) FORMULATIONS OF (S) -3- (4 - ((4-MORPHOLINOMETHYL) BENZYLXYL) -1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE
IL231958A0 (en) Solid dosage forms of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2- trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate
UY34329A (en) TRIAZOLOPIRIDINE COMPOUNDS
CL2014003459A1 (en) Heterocyclic fungicidal compounds.
SMT201600421B (en) 7-METHYL-2- [4-METHYL-6- [4- (trifluoromethyl) phenyl] pyrimidin-2-IL] -1,7-diazaspiro [4.4] nonan-6-ONE
UY34791A (en) N-ETHYL-4-HYDROXYL-1-METHYL-5- (METHYL (2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) -2-OXO-N-PHENYL-1,2- DIHYDROQUINOLINE-3-CARBOXAMIDE
DK2748147T3 (en) Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
CL2013000797A1 (en) Preparation process for (2r, 3r) -3- {4- (s- (cyclo) alkyl-sulfonimidoyl) phenyl} amino} -5- (trifluoromethyl) pyrimidin-4-yl} oxy} butan-2-2ol inhibitors; and the intermediary compounds considered.
TH148782B (en) Dosage form (S) - ethyl-2-amino-3- (4- (2- amino-6 - ((R) -1- (4- chloro-2- (3-methyl- 1H-pyrazol-1-il) phenyl) -2,2,2-trifluoroethoxy) pyrimidin-4-il) phenyl) propano Et ((S) -ethyl-2-amino-3- (4- (2-amino-6 - ((R) -1- (4-chloro-2- (3-methyl-1H-pyrazol-1-y1)) phenyl) -2,2,2-trifluoroethoxy) pyrimidin-4-yl) phenyl) propanoate)
DK3057580T3 (en) PHARMACEUTICAL FORM OF ADMINISTRATION CONTAINING SODIUM-1- [6- (MORPHOLIN-4-YL) PYRIMIDIN-4-YL] -4- (1H-1,2,3-TRIAZOL-1-YL) -1H-PYRAZOLE-5-OLATE
CL2014001265A1 (en) Compounds derived from uracil, axl and c-met kinase inhibitors, useful in the treatment of cancer.
CU20120001U (en) GATEADOR, WALKER, CORRAL
ITPT20130011U1 (en) ANATOMIC INSOLE CONCAVE, FOR SANDALS IN GENERAL